No Data
No Data
Benign Growth For Weihai Baihe Biology Technological Co., Ltd. (SHSE:603102) Underpins Its Share Price
Lilly Co., Ltd. (603102.SH): First repurchase of 0.14% of shares.
On March 10, Glonhui reported that Lianhuan Co., Ltd. (603102.SH) announced that on March 10, 2025, the company repurchased 92,400 shares of its A-shares through the Shanghai Exchange system via a centralized bidding method, accounting for 0.14% of the company's current total share capital. The highest Fill Price for the buyback was 35.00 yuan per share, the lowest Fill Price was 34.64 yuan per share, and the total amount paid was 3,218,092 yuan (excluding stamp duty, trading commissions, and other transaction costs).
Lily Co., Ltd. (603102.SH): The buyback term is more than half over, and the buyback has not yet been implemented.
Gelonghui, February 10 - Baihe Co., Ltd. (603102.SH) announced that as of the date of this announcement, the implementation period for the share repurchase has passed its halfway point, and the company has not yet repurchased any shares. As of February 10, 2025, the company has cumulatively repurchased 0 Stocks through centralized bidding Trade, accounting for 0% of the company's total share capital, with a total payment amount of 0 yuan (excluding transaction costs).
Fangzheng Securities: The selection model for supermarkets is rapidly developing. Attention is drawn to the supply chain of high-quality leaders in the CSI SWS Food & Beverage index.
Currently, online traffic growth is slowing down, while offline channels are regaining some customer flow. Among these, the share of traditional key account large supermarkets is rapidly shrinking, whereas specialty selection model supermarkets are beginning to thrive.
Lily Co., Ltd. (603102.SH): Has not repurchased company shares.
Gelonghui November 1st | Lianhe Shares (603102.SH) announced that as of October 31, 2024, the company has not repurchased company shares through centralized auction trading.
Weihai Baihe Biology Technological's (SHSE:603102) Problems Go Beyond Weak Profit